Clinical Trials Insight: 700015653
Phase of Trial: Phase II
Latest Information Update: 24 Jul 2009
At a glance
- Drugs Adecatumumab (Primary)
- Indications Advanced breast cancer
- Focus Pharmacogenomic; Therapeutic Use
- 24 Jul 2009 Primary endpoint 'clinical-benfit-rate (complete clinical response + partial clinical response + stable disease)' has not been met according to results published in the Annals of Oncology.
- 05 Oct 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History